GSK Investigational Site
Zhanjiang 524045
1 studies enrolling now · 3 studies all time
What they study most
Asthma, Bronchiectasis, Cough, Refractory Chronic Cough
Studies at this site
- A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis — Recruiting now
- A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough — Running, not enrolling
- Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed